Introduction
============

The conserved catabolic pathway of autophagy is essential to generate an internal pool of nutrients that permit cells to survive during prolonged periods of starvation ([@bib27]). Recent studies have revealed that because of its ability to eliminate unwanted structures, autophagy also participates in development, cellular differentiation, degradation of aberrant structures, and life span extension, as well as protecting against pathogens and tumors ([@bib22]; [@bib23]; [@bib27]). As a result, this pathway plays a relevant role in the pathophysiology of neurodegenerative, cardiovascular, muscular, and autoimmune diseases.

The general mechanism of autophagy involves the sequestration of the cytoplasmic cargo into large double-membrane vesicles called autophagosomes that fuse with lysosomes/vacuoles to provide their contents with access to the hydrolytically active interior of these organelles, thus allowing for the cargo's degradation. The current model of autophagosome biogenesis is that they are formed by expansion and successive sealing of a small membrane cisterna termed the phagophore or isolation membrane ([@bib35]). The phagophore appears to be generated at a specialized site called the preautophagosomal structure or the phagophore assembly site (PAS; [@bib52]). Most of the studies about the PAS have been done in the yeast *Saccharomyces cerevisiae*, where only one of these structures is present in each cell and it is found in proximity to the vacuole ([@bib52]). These investigations have revealed that the autophagy-related (Atg) proteins, the components of the conserved machinery mediating autophagosome biogenesis, assemble according to a hierarchical order and form this specialized site ([@bib48]). Despite the apparent importance of the PAS, very little is known about this site at the molecular level, including the origin of the nucleating membrane and the subsequent rearrangements that allow it to form a sequestering compartment.

Most of the Atg proteins are cytosolic and transiently associate with the PAS by interacting with other Atg components and/or lipids. Atg9 is the only conserved integral membrane protein that is essential for autophagosome formation ([@bib21]; [@bib29]; [@bib54]). In yeast, *Atg*9 localizes to several puncta dispersed throughout the cytoplasm, some of which colocalize with mitochondria markers; however, it remains unclear whether they are part of the outer membrane of this organelle or adjacent to it ([@bib38], [@bib40]). Atg9 cycles between these peripheral puncta (hereafter referred as the Atg9 reservoirs), which do not contain detectable levels of most other conserved Atg proteins, and the PAS, which supports the notion that Atg9 is involved in the delivery of membrane necessary for the formation of the sequestering vesicles ([@bib38]). In addition, Atg9 is one of the first Atg components to be localized to the PAS ([@bib48]). In *atg9Δ* cells, nearly all the other Atg proteins fail to be recruited to the PAS, making its role crucial in the assembly of the Atg machinery.

The key organizational function of Atg9 is also exemplified by the fact that Atg9 transport to the PAS is regulated during the yeast cytoplasm-to-vacuole targeting (Cvt) pathway, a biosynthetic selective type of autophagy devoted to the delivery into the vacuole of cytosolic oligomers mostly formed by the precursor vacuolar protease aminopeptidase I (prApe1; [@bib20]). After oligomerization, the prApe1 complex binds to its receptor, Atg19, to form the Cvt complex, which is subsequently recruited near the vacuole surface in an Atg11-dependent step ([@bib43]). Atg11 also binds Atg9 and thus mediates the simultaneous movement of both the Cvt complex and Atg9 ([@bib43]; [@bib42]; [@bib13]). This regulated relocation triggers the recruitment of the Atg proteins to the PAS and subsequent sequestration of the Cvt complex into a double-membrane Cvt vesicle ([@bib42]).

Despite the important progress made in understanding autophagy, the study of the precise function of these factors as well as the mechanism of this pathway has been hampered by the lack of information regarding the membrane dynamics during the autophagosome formation process. To gain insights into this crucial question, we have studied the biogenesis of the yeast PAS by combining a recently developed immunoelectron microscopy (IEM) protocol ([@bib10]) with yeast genetics. We show that the PAS originates from Atg9-positive clusters of vesicles and tubules that we called Atg9 reservoirs. Translocation of one or more reservoirs in proximity to the vacuole, together with the successive recruitment of other Atg proteins, generates the PAS. Hence, fusion of the tubulovesicular membranes of the Atg9 reservoirs leads to the formation of the phagophore necessary for the subsequent biogenesis of a double-membrane vesicle. Thus, our results suggest the de novo formation of the PAS from vesicles and tubules and highlight the crucial role of Atg9 in this process.

Results
=======

Atg9 localizes to tubulovesicular clusters adjacent to mitochondria
-------------------------------------------------------------------

It has been proposed that Atg9 is one of the factors mediating the transport of lipid bilayers to the PAS ([@bib38]). Consequently, the identification of the membranes positive for Atg9 is crucial to understand the nature and biogenesis of the PAS, and its role in autophagosome formation. Fluorescence microscopy has shown that Atg9 resides in numerous puncta, some of them partially colocalizing with or near mitochondria ([@bib40]; [@bib36]). This approach, however, does not make it possible to determine the nature of the Atg9 compartments and their structural relationship with mitochondria. To unveil their morphology and acquire mechanistic insights into their contribution to PAS formation, we analyzed the localization and trafficking of Atg9 at the ultrastructural level using a recently developed IEM procedure ([@bib10]). As the cellular levels of endogenous Atg9 are too low for IEM detection, we created a functional C-terminal GFP fusion protein (Atg9-GFP), which behaves like the endogenous one ([Fig. 1](#fig1){ref-type="fig"}).

![**The Atg9-GFP construct for IEM analyses.** (A) The prApe1 processing is normal in Atg9-GFP--expressing cells. The *atg9Δ* (JCK007) mutant transformed with either an empty vector (pRS416), a plasmid carrying the *ATG9* gene (pJK1-2416), or the ATG9-GFP fusion (pATG9GFP416) was grown in YPD medium to log phase before analyzing prApe1 maturation by immunoblotting. The cytosolic protein Pgk1 was used as a loading control. M~r~ is indicated in kilodaltons. The black line indicates that intervening lanes have been spliced out. (B) Autophagy is normal in the presence of Atg9-GFP. The *atg9Δ* (FRY300) cells expressing Pho8Δ60 and transformed with the same plasmids described in A were shifted from YPD medium (dark gray bars) to SD-N medium (light gray bars) for 4 h. Autophagy induction was determined by a Pho8 activity assay. (C and D) Atg9-GFP has a normal distribution, and one of the Atg9-GFP-containing puncta is the PAS. Strains expressing Atg9-GFP under the control of the *ATG9* promoter (FRY162) or the *TPI1* promoter (MMY067) were transformed with a plasmid (promRFPATG8415) carrying the PAS protein marker RFP-Atg8. (C) Transformants were cultured to log phase and imaged. The number of Atg9-GFP puncta per cell was counted (D) and error bars represent the standard deviation of the mean. Arrowheads highlight colocalizations. (E and F) Part of Atg9-GFP distributes to mitochondria. The strains analyzed in C were transformed with the pmitoDsRed415 plasmid expressing mitochondria-targeted RFP and imaged (E). Arrowheads highlight Atg9 puncta adjacent to mitochondria. Determination of Atg9-GFP puncta distribution on mitochondria (F) was determined as described in Materials and methods, and error bars represent the standard deviation of the mean. DIC, differential interference contrast. Bar, 2 µm.](JCB_200912089R_RGB_Fig1){#fig1}

Wild-type cells expressing Atg9-GFP were grown in rich medium and prepared for IEM. The vast majority of Atg9-GFP was present in clusters of vesicular (mean diameter of 30--40 nm) and tubular structures ([Fig. 2, A--D](#fig2){ref-type="fig"}; and [Fig. S1](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1)). The Atg9 clusters (defined in Materials and methods) were found in 53% of the cells, and their numbers vary from one to three, with occasionally four, per cell section ([Table I](#tbl1){ref-type="table"}). The gold particles corresponding to Atg9-GFP decorated the cytosolic surface of these membranes, in agreement with Atg9 topology that predicts GFP fused to the C terminus to be on the cytosolic face of lipid bilayers ([@bib13]). Interestingly, the Atg9 clusters were occasionally seen surrounding a circular electron-dense cytoplasmic structure with a diameter of 100--150 nm ([Figs. 2 D](#fig2){ref-type="fig"} and S1, A \[arrowhead\] and E). Double immunogold labeling for GFP and Ape1 identified it as the Cvt complex ([Figs. 2 E](#fig2){ref-type="fig"} and S1 B; [@bib1]). When more than one Atg9 cluster was observed in a cell section, only one of them was associated with a Cvt complex ([Tables I](#tbl1){ref-type="table"} and [II](#tbl2){ref-type="table"}; 1% of the cell sections are Cvt complex positive). In contrast, the Cvt complex was associated with an Atg9 cluster in 80% of the cells where the former was detected, reflecting the close association between these two structures ([@bib13]).

![**IEM analysis of wild-type cells expressing Atg9-GFP.** Atg9-GFP (MMY067) cells were grown to log phase and processed for IEM as described in Materials and methods. Preparations shown in A--D were immunogold labeled only for GFP, whereas those presented in E were double immunogold labeled for GFP and Ape1. (A) Overview of a labeled cell section. (B) Insets of A illustrating an Atg9-positive cluster of vesicles and tubules. (C) Atg9-containing membranous arrangements (arrow) adjacent to mitochondria (**≤** 50 nm distance). (D) Micrograph showing a GFP-labeled cell with two Atg9 clusters (marked by an arrow and an arrowhead), one of which (arrowhead) associated with an electron-dense structure with a 100--150 nm diameter (broken lines). (E) The circular electron-dense structures found in close proximity to the Atg9 clusters and labeled for Ape1 are Cvt complexes (broken lines). The dashed cisterna emphasizes the Cvt complex surface not associated with Atg9-containing membranes. D and E are also shown in [Fig. S1 (A and B)](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1) without broken lines for clarity, while additional examples of Atg9 clusters are presented in Fig. S1, C--H. The size of the gold particles is indicated on the top of each picture. CW, cell wall; M, mitochondria; MVB, multivesicular body; N, nucleus; PM, plasma membrane; V, vacuole. Bars, 200 nm.](JCB_200912089R_GS_Fig2){#fig2}

###### 

Frequency of the Atg9-GFP containing structures and the Cvt complex

  Criteria                                                    Strain background                                                
  ----------------------------------------------------------- ------------------- -------------------------------------------- -------------------------------------------
  **Atg9-GFP--containing membranous clusters/cell section**                                                                    
  0                                                           47 ± 1.8            57 ± 2.3                                     84 ± 1.2
  1                                                           28 ± 1.3            25 ± 0.8                                     14 ± 0.7[a](#tblfn1){ref-type="table-fn"}
  2                                                           19 ± 0.9            16 ± 0.8                                     2 ± 0.2[a](#tblfn1){ref-type="table-fn"}
  3                                                           5 ± 0.8             2 ± 1.1                                      0
  ≥4                                                          1 ± 0.2             0                                            0
  **Cvt complex/cell section**                                                                                                 
  0                                                           99 ± 0.1            99.7 ± 0.3                                   95 ± 0.8
  1                                                           1 ± 0.4             0.3 ± 0.1[a](#tblfn1){ref-type="table-fn"}   5 ± 0.8[a](#tblfn1){ref-type="table-fn"}
  2                                                           0                   0                                            0
  3                                                           0                   0                                            0
  ≥4                                                          0                   0                                            0

Counting and statistical analyses were carried out as described in Materials and methods. All the results are expressed in percentages ± the standard error of the mean.

P ≤ 0.05.

###### 

Relative subcellular distribution of the Atg9-GFP containing structures and Cvt complex

  Criteria/cell type                                                           Location                               
  ---------------------------------------------------------------------------- ------------ ------------ ------------ ------------
  **Atg9-GFP--containing membranous clusters**                                                                        
  WT                                                                           57.0 ± 0.2   3.8 ± 0.05   4.9 ± 0.05   34.3 ± 0.1
  *atg11Δ*                                                                     50 ± 0.4     4 ± 0.3      2 ± 0.03     44 ± 0.1
  *atg1Δ*                                                                      17.5 ± 0.1   37.5 ± 0.1   7.5 ± 0.05   37.5 ± 0.2
  **Cvt complexes associated with Atg9-GFP--containing membranous clusters**                                          
  WT                                                                           58.8 ± 0.3   2.0 ± 0.1    3.9 ± 0.2    35.3 ± 0.3
  *atg11Δ*                                                                     ND           ND           ND           ND
  *atg1Δ*                                                                      14.3 ± 0.2   57.1 ± 0.2   12.2 ± 0.5   16.4 ± 0.8
  **Free Cvt complexes**                                                                                              
  WT                                                                           2.2 ± 0.2    0            0            97.8 ± 0.3
  *atg11Δ*                                                                     15.4 ± 1.1   0            1.2 ± 0.8    83.4 ± 1.5
  *atg1Δ*                                                                      ND           ND           ND           ND

Counting and statistical analyses were carried out as described in Materials and methods. All the results are expressed in percentages ± the standard error of the mean. ND, not determined because this structure is not present or very rare in the indicated strain.

In agreement with the fluorescence microscopy data ([@bib40]; [@bib13]; [@bib36]), the Atg9 clusters were predominantly adjacent to mitochondria (57%, [Table II](#tbl2){ref-type="table"}), but they were never seen continuous with the outer membrane of this organelle. To reinforce the notion that these clusters are separated from mitochondria, we immunolocalized Por1, a component of the mitochondrial outer membrane. The Por1 was found exclusively on the surface of mitochondria and was absent from the Atg9-containing clusters ([Fig. 3 A](#fig3){ref-type="fig"}). An identical result was also obtained with Idh1, another mitochondrial protein marker ([Fig. 3, B--F](#fig3){ref-type="fig"}).

![**Mitochondrial protein markers do not localize to the Atg9 clusters.** (A) Ultrathin cryosections obtained from a wild-type (MMY067) strain were immunogold labeled only for Por1 because the anti-Por1 antibody does not work in double labeling. The broken line highlights an Atg9 cluster. (B--F) Cells expressing both Atg9-GFP and the mitochondrial marker Idh1-3xHA (MOY003) were processed for IEM, and cryo-sections were double immunogold labeled for GFP and HA. CW, cell wall; M, mitochondria; N, nucleus; PM, plasma membrane; V, vacuole. Bars, 200 nm.](JCB_200912089_GS_Fig3){#fig3}

In parallel, we addressed whether higher levels of Atg9-GFP were altering the Atg9 reservoirs morphology. When we analyzed an untransformed wild-type strain by IEM, we detected identical clusters adjacent to mitochondria, albeit with a reduced size ([Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1)). To determine if these clusters showed similar biophysical properties in wild-type and Atg9-GFP--overexpressing cells, cell extracts were centrifuged at 13,000 *g*. Under these conditions, most of the endogenous Atg9 was found in the low-speed supernatant (S13) fraction and only a small amount in the pellet (P13) fraction (Fig. S2 B; [@bib39], [@bib40]). The reduction in the amount of Atg9 in the P13 fraction in comparison to previously published data ([@bib40]) may represent more efficient spheroplast lysis. Using the same approach for cells overproducing Atg9-GFP, we found this fusion protein in the S13 fraction (Fig. S2 B). This result indicates that higher levels of Atg9 change the volume of the Atg9 clusters to accommodate more protein but that they do not alter their biophysical properties. Similar enlargements have been reported for other organelles like the ER, where overproduction of a resident protein leads to ER expansion without altering its physiology ([@bib51]).

We concluded that the Atg9-containing compartments consist of a cluster of vesicles and tubules that are often in the vicinity of mitochondria, but not connected with them.

Atg9 resides in a novel compartment originating from the secretory system
-------------------------------------------------------------------------

The proximity of the Atg9 clusters adjacent to, but distinct from, mitochondria raised the question of their biogenesis. As Atg9 is a transmembrane protein, it could be inserted into membranes either in the mitochondria or in the ER.

To follow the Atg9 biosynthetic route, Atg9-GFP expression was put under the control of the galactose-inducible *GAL1* promoter. Transfer into a galactose-containing medium for 2 h allowed us to detect Atg9 clusters ([Fig. 4](#fig4){ref-type="fig"}). No intermediate structures, e.g., mitochondria or ER, were visualized even at earlier time points, probably due to the rapid transport of Atg9 after synthesis. To further explore whether Atg9 is transported through the secretory pathway, we used a strain carrying a thermosensitive allele of *SEC12*, which blocks ER exit ([@bib2]). At a permissive temperature, the localization pattern of Atg9-GFP was indistinguishable from that observed in wild-type cells ([Fig. 4 A](#fig4){ref-type="fig"}). At a restrictive temperature, in contrast, the transport block between the ER and Golgi apparatus resulted in the accumulation of newly synthesized Atg9 in the ER, as revealed by colocalization with the specific protein marker Sec63 ([Fig. 4 A](#fig4){ref-type="fig"}; [@bib4]). This transport block was reversible, which indicates that Atg9-GFP was not amassed in a terminal structure but rather accumulated in a transport intermediate (unpublished data). To examine the role of the Golgi complex in Atg9 transport, we used a thermosensitive *sec7* allele, which blocks protein traffic from this organelle but does not affect localization of the protein ([@bib6]; [@bib18]). At 24°C, Atg9-GFP was again normally distributed to several cytoplasmic puncta, and those were only rarely positive for the late Golgi compartment protein marker Sec7 ([Fig. 4 B](#fig4){ref-type="fig"}; [@bib25]). In contrast, at 37°C, newly synthesized Atg9-GFP was present in circular structures, often positive for Sec7^ts^ tagged with *Discosoma* red fluorescent protein (dsRed), which occasionally had an elongated conformation ([Fig. 4 B](#fig4){ref-type="fig"}, arrows). These structures are likely Berkeley bodies, aberrant Golgi generated as a result of the *sec7* sorting defect ([@bib30]). Again, the transport block was reversible, which indicates that Atg9-GFP was not accumulated in a terminal structure (unpublished data). We concluded that Atg9 is translocated into the ER and reaches its final destination, the Atg9 clusters, probably after passing through the Golgi.

![**Atg9 is transported through part of the secretory pathway.** (A) Atg9 is translocated into the ER. The wild-type (MMY126) and *sec12* (MMY129) cells expressing Sec63-mChe-V5 and carrying the pGalATG9GFP416 plasmid were grown in SMD at 24°C before being transferred into a galactose-containing medium. Cultures were subsequently split and separately incubated at either 24°C or 37°C for 2 h before imaging. No fluorescence signal was detected when cells were grown in the presence of glucose (not depicted). (B) Atg9 passes through the Golgi before reaching its final destination. Wild-type (MMY125) and *sec7* (MMY127) cells expressing genomically mChe-V5--tagged Sec7 and Sec7^ts^, respectively, and transformed with the pGalATG9GFP416 plasmid were analyzed as in A. Arrows highlight the colocalization between Atg9-GFP and Sec7^ts^-mChe in *sec7^ts^* cells at 37°C. DIC, differential interference contrast. Bars, 2 µm.](JCB_200912089_RGB_Fig4){#fig4}

As a post-Golgi organelle, the Atg9 clusters could be endosomes. To test this possibility, we used FM 4-64, a lipophilic dye that, after associating with the plasma membrane, passes through endosomes before reaching the vacuole ([@bib50]). At 4°C, endocytosis is inhibited and FM 4-64 exclusively associates with the plasma membrane. Transfer of FM 4-64--loaded cells to RT allows the internalization of this dye in a time-dependent manner ([@bib45]). After 10 min at RT, FM 4-64 reached early endosomes (EE; [@bib45]), as demonstrated by the extensive colocalization with the specific protein marker Tlg1 ([Fig. 5 A](#fig5){ref-type="fig"}; [@bib15]). Several Atg9 clusters were faintly positive for FM 4-64 at the same internalization time point ([Fig. 5 A](#fig5){ref-type="fig"}, arrows).

![**Atg9 concentrates into a novel organelle.** (A) Atg9-GFP colocalizes with some FM 4-64-positive puncta shortly after endocytosis. The strains expressing genomically GFP-tagged Tlg1 (FRY360) or Atg9 (FRY162) were grown to log phase and then exposed to FM 4-64 as described in Materials and methods. Arrowheads highlight the colocalization between FM 4-64 and GFP-Tlg1 or Atg9-GFP. (B) Atg9 does not colocalize with endosomal and Golgi protein markers. The Atg9-GFP Vrg4-mChe-V5 (FRY340), Atg9-GFP Sec7-dsRED (FRY341), GFP-Tlg1 Atg9-mChe-V5 (FRY342), and GFP-Pep12 Atg9-mChe-V5 (FRY344) strains were grown to log phase before being fixed and imaged. Bars, 2 µm. (C) The colocalization experiments shown in B were statistically evaluated as described in Materials and methods. Atg23 was used as a positive control for colocalization because forming a complex with Atg9 ([@bib38]). DIC, differential interference contrast.](JCB_200912089_RGB_Fig5){#fig5}

The fact that the Atg9 clusters are connected with the endocytic and secretory systems prompted us to investigate whether known protein markers of these compartments localized on Atg9 clusters. We created strains expressing Atg9-GFP together with dsRed- or Cherry-tagged Tlg1 (EE), Pep12 (late endosomes \[LE\]), Vrg4 (early Golgi), Sec7 (late Golgi), and Atg23 (colocalizes with Atg9; [@bib15]; [@bib25]) under the control of the endogenous promoters. As expected, Atg23 displayed substantial colocalization with Atg9 ([Fig. 5 C](#fig5){ref-type="fig"}). In contrast, the tagged endosomal and Golgi proteins did not ([Fig. 5, B and C](#fig5){ref-type="fig"}).

Collectively, our results show that the Atg9 clusters represent a novel compartment originating from the secretory pathway and able to exchange at least lipids with the endocytic system.

The Atg9 reservoirs and the PAS have a similar morphological organization
-------------------------------------------------------------------------

Atg9 is a highly dynamic protein that shuttles between the Atg9 reservoirs and the PAS ([@bib38]; [@bib8]). Therefore, one of the observed Atg9 clusters described could represent the PAS. In wild-type cells it is not possible to distinguish the PAS from the Atg9 reservoirs. Therefore, we capitalized on certain characteristics of the Cvt pathway for two reasons: (1) it uses primarily the same Atg machinery as autophagy, and (2) specific gene deletions can modulate Atg9 trafficking. For instance, Atg11 is essential for both the association between Atg9 and the Cvt complex, and their transport near the vacuole in growing conditions, where they recruit the Atg proteins ([Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1); [@bib13]). As a consequence, no PAS is formed in the *atg11Δ* strain (Fig. S3 B; [@bib42]), and this allows exclusive visualization of the Atg9 reservoirs.

IEM analysis of the *atg11Δ* cells revealed that the Atg9 clusters adjacent to mitochondria are the Atg9 reservoirs ([Fig. 6, A and B](#fig6){ref-type="fig"}; [Fig. S4, A--C](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1); and [Table II](#tbl2){ref-type="table"}). The Atg9-positive structures were found in 43% of the cell sections, and the subcellular distribution of these compartments was identical to that observed in wild-type cells, which shows that the Atg9 reservoirs are the main site of Atg9 concentration ([Table II](#tbl2){ref-type="table"}). As expected, the Atg9 reservoirs were no longer associated with Cvt complexes in agreement with the described phenotype of the *atg11Δ* mutant (Fig. S3 A; [@bib13]).

![**Atg9-GFP distribution in various *atg* mutants.** The *atg11Δ* (MMY069; A and B), *atg1Δ* (MMY068; C and D), *atg13Δ* (MMY070; E and F), and *atg14Δ* (MMY071; G and H) strains were grown and processed as described in [Fig. 2](#fig2){ref-type="fig"}. Cryosections were immunolabeled for GFP alone (A, B, and D--J) or in combination with Ape1 (C). (A and B) The Atg9 reservoirs observed in *atg11Δ* cells. (C and D) The PAS accumulated in the *atg1Δ* knockout. (E and F) The PAS present in the *atg13Δ* strain displays a Cvt complex surrounded by numerous small vesicles. (G and H) Enrichment of tubular membranes at the PAS of the *atg14Δ* mutant. Cvt complexes are highlighted with broken lines. D--F are also shown in [Fig. S4 (E, F, I, and J)](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1) without dashed lines for clarity, while additional examples are presented in Fig. S4 (A--D, G, H, and K--Q). CW, cell wall; M, mitochondria; N, nucleus; PM, plasma membrane; V, vacuole. Bars, 200 nm.](JCB_200912089_GS_Fig6){#fig6}

We then used a similar genetic approach to capture the PAS and analyze its ultrastructure. Deletion of *ATG* genes blocks PAS assembly at a precise stage ([@bib48]). Under these conditions, this specialized site is identified by fluorescence microscopy as a perivacuolar punctum positive for the Cvt complex and for several Atg proteins, the array of which depends on the knocked out gene ([@bib48]). Atg1 is one of the first proteins to be recruited to the PAS, and consequently, an early formation intermediate accumulates when it is absent ([@bib48]). Crucially, Atg9 is exclusively localized at the PAS in *atg1Δ* cells because it cannot recycle to the reservoirs (Fig. S3; [@bib38]), providing an excellent tool to capture the forming PAS. Remarkably, the PAS appeared as a single cluster of Atg9-containing vesicles and tubules, very similar to the Atg9 reservoirs observed in wild-type and *atg11Δ* cells ([Fig. 6, C and D](#fig6){ref-type="fig"}; and Fig. S4, D--H). A main difference was that this single cluster was detected in fewer cells ([Table I](#tbl1){ref-type="table"}; 16% of the cell sections in comparison with 53% and 43% for wild-type and *atg11Δ*, respectively) and was no longer located in close proximity to the mitochondria, but was mostly adjacent to the vacuole ([Table II](#tbl2){ref-type="table"}; 37% of the time), which reinforces the notion that it corresponds to the PAS ([@bib48]). Furthermore, this cluster was associated with the Cvt complex in 94% of the cases, which confirms its PAS identity ([Fig. 6, C and D](#fig6){ref-type="fig"}; and Fig. S4, E--H).

To corroborate the conclusions drawn from the examination of the *atg1Δ* mutant, we next analyzed the PAS in *atg13Δ* and *atg14Δ* cells, where the PAS biogenesis is also blocked at an early assembly stage ([@bib48]) and Atg9 is accumulated at this site (Fig. S3; [@bib38]). Similar to *atg1Δ* cells, the number of Atg9 reservoirs was strongly reduced in these mutants, and when detected, they were often in association with the Cvt complex and proximal to the vacuole, further suggesting that this is indeed the PAS ([Fig. 6, E--H](#fig6){ref-type="fig"}; and Fig. S4, I--Q). Strikingly, the PAS observed in the absence of *ATG13* and *ATG14* displayed a slightly different morphology from that of *atg1Δ* cells. In the *atg13Δ* knockout ([Fig. 6, E and F](#fig6){ref-type="fig"}; and S4, I--M), the PAS was comprised almost entirely of small vesicular profiles with a diameter of ∼25--30 nm, whereas in the *atg14Δ* mutant, more and longer tubular profiles were present in this structure, which in general appeared to be larger ([Fig. 6, G and H](#fig6){ref-type="fig"}; and Fig. S3, N--Q).

Together, our data strongly support the concept that the PAS is a vesicular and tubular cluster with morphology very similar to Atg9 reservoirs. The data also indicate that double-membrane vesicles are formed through a process that initially requires the fusion/remodeling of these membranes through the direct or indirect functions of Atg1, Atg13, and Atg14.

The Atg9 reservoirs participate in the generation of the PAS
------------------------------------------------------------

The strong morphological similarity between the Atg9 reservoirs and the PAS suggests that the latter originates from the former. If so, these two structures are expected to have similar biochemical properties. To test this, we fractionated intracellular membranes of wild-type, *atg11Δ*, and *atg1Δ* strains. Cell extracts were first centrifuged at 13,000 *g*. In all three strains, most of the Atg9 was found in the low speed S13 fraction and only a small amount in the pellet P13 fraction ([Figs. 7 A](#fig7){ref-type="fig"} and S2 B; [@bib39], [@bib40]). The S13 supernatant fraction was then separated on a sucrose step-density gradient ([@bib39]). From wild-type cells, Atg9 fractionated in a single peak that was for the most part distinct from EE and LE ([Fig. 7, B and C](#fig7){ref-type="fig"}). Importantly, the Atg9 reservoirs and the PAS that accumulated in the *atg11Δ* and *atg1Δ* mutant, respectively, are also present in the same fractions ([Fig. 7, B and C](#fig7){ref-type="fig"}). This finding indicates that the Atg9 reservoirs and the PAS have almost identical densities, which supports the notion that the PAS could be derived from the Atg9 reservoirs.

![**Subcellular fractionation of Atg9 clusters in wild-type, *atg11Δ*, and *atg1Δ* backgrounds.** (A) The Atg9-PA (FRY172), Atg9-PA *atg11Δ pep4Δ* (FRY250), and Atg9-PA *atg1Δ pep4Δ* (FRY196) strains were grown to log phase, converted to spheroplasts, and lysed, then cell extracts were centrifuged at 13,000 *g* for 15 min. The cell extract (T), the supernatant (S13), and the pellet (P13) fractions were then separated by SDS-PAGE, and Atg9 distribution was analyzed by Western blotting using anti-PA antibodies. Efficient lysis and correct fractionation were assessed by verifying the partitioning of cytosolic Pgk1 and mitochondrial Por1. M~r~ is indicated in kilodaltons. (B) The S13 supernatants were fractionated on sucrose step-density gradients, and the fractions were analyzed by Western blotting using antisera against PA (for Atg9-PA), Pep12, Tlg1, and Pgk1. (C) Quantification of the immunoblots.](JCB_200912089_GS_Fig7){#fig7}

Two possible models could explain how the PAS is generated from the Atg9 reservoirs. In the first, reservoirs translocate en bloc toward the vacuole, whereas in the second model, single vesicles derived from one or more reservoirs assemble near the vacuole. To determine how the PAS is generated from the Atg9 reservoirs, we took advantage of the fact that Atg9 transport to the PAS requires the Cvt complex in growing conditions, but not when autophagy is induced ([@bib42]). In the *ape1Δ atg1Δ* double-knockout cells maintained in growing conditions, therefore, Atg9 remains locked in the Atg9 reservoirs, whereas it accumulates at the PAS when these cells are starved ([@bib42]). To determine how Atg9 is transported from the Atg9 reservoirs to the PAS, we followed the relocalization of Atg9 in the *ape1Δ atg1Δ* mutant by IEM over time (up to 1 h) after autophagy induction by nitrogen starvation. At the early time points, the only Atg9-positive structures we identified were clusters of vesicles and tubules; these corresponded to the Atg9 reservoirs, as they were often found, in 47% of the cases, adjacent to the mitochondria ([Fig. 8, A and D](#fig8){ref-type="fig"}). Before starvation (time 0 min), 40% of the cell profiles were positive for 1--3 Atg9 reservoirs. In contrast, 60 min after the induction of autophagy, only 14% of the cell profiles were positive for Atg9 clusters and only one of them was observed per cell section. The Atg9-positive compartments were mostly found close to the vacuole after 60 min ([Fig. 8, B--D](#fig8){ref-type="fig"}). This observation is in line with the design of the experiment, which predicts an *atg11Δ*-equivalent phenotype (43% of cell profiles positive for 1--3 Atg9 clusters) before autophagy induction and an *atg1Δ* phenotype (16% of cell profiles positive for one Atg9 compartment) after starving the cells. The observed phenotypes were not caused by a structural reorganization of the Atg9 clusters, e.g., fusion and fission, because the mean surface section of the Atg9 clusters is very similar at the 0 and 60 min time points (0.121 and 0.139 mm^2^, respectively; *t* test assessment of the individual measurements revealed no significant difference between the values; P = 0.09). Importantly, we did not observe a significant increase in the total number of isolated Atg9-positive vesicles in the cytoplasm, which supports the notion that Atg9 reservoirs translocate en bloc ([Fig. 8 E](#fig8){ref-type="fig"}).

![**The Atg9 reservoirs move en bloc to become the PAS.** The *ape1Δ atg1Δ* (MMY078) double mutant was grown to log phase before being nitrogen starved to induce autophagy. Cell aliquots were collected after 0, 10, 20, 30, 45, and 60 min. They were then processed for IEM, and cryosections were immunogold labeled for GFP (A--C). (A) An Atg9 reservoir adjacent to a mitochondrion observed at the 0 min time point. (B and C) Atg9 clusters close to the vacuole limiting membrane detected after 60 min of starvation. The gold particles size is indicated on the top of each picture. M, mitochondria; V, vacuole. Bars, 200 nm. (D) Relative subcellular distribution of the Atg9-GFP clusters in the *ape1Δ atg1Δ* cells before and after induction of autophagy for 60 min. Statistical analyses were performed as described in Materials and methods. (E) The number of isolated Atg9-positive vesicles in the cytoplasm does not increase after triggering Atg9 relocalization in the *ape1Δ atg1Δ* mutant by autophagy induction. 100 cell profiles were randomly selected and the number of isolated Atg9-positive vesicles per cell profile was established. Results in D and E are expressed in percentages ± the standard error of the mean (error bars).](JCB_200912089_GS_Fig8){#fig8}

To further demonstrate that the Atg9 reservoirs are the PAS precursor, we analyzed the evolution of this compartment by time-lapse fluorescence microscopy. At present, the primary distinguishing feature of the PAS is that most of the Atg proteins associate at least transiently with this site. Thus, the idea behind this experiment is that an Atg9 reservoir should acquire the rest of the conserved Atg proteins as it becomes a PAS. To test this hypothesis, we generated a strain expressing higher levels of Atg9-monomeric cherry (mChe) to avoid rapid bleaching of the red fluorescent protein, allowing longer recording intervals. In addition, *ATG8* was genomically tagged with *GFP* in the same cells. We selected Atg8 as a PAS protein marker because this factor is the last Atg protein to be recruited at this site ([@bib48]), and consequently, its presence at the PAS reflects the complete assembly of the Atg machinery. The engineered cells were then grown to logarithmic (log) phase before being transferred in SD-N medium for 20 min and imaged. Nitrogen starvation was used to induce autophagy because under these conditions, double-membrane vesicles form at a higher frequency, increasing the chance of capturing PAS biogenesis. As shown in [Fig. 9](#fig9){ref-type="fig"} and [Video 1](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1), this approach allowed us to observe Atg9 reservoirs becoming the PAS; GFP-Atg8 was seen to move from a cytosolic location and ultimately colocalized with a reservoir. Importantly, the same result was obtained with cells expressing endogenous Atg9-GFP and carrying a plasmid expressing mChe-Atg8 ([Video 2](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1)). These results demonstrate that the PAS originates from the Atg9 reservoirs, and consequently, this latter compartment supplies at least part of the phagophore membrane. They also further support the notion that the Atg9 reservoirs translocate en bloc to become the PAS.

![**Live cell imaging of an Atg9 reservoir becoming the PAS.** Atg9-mChe GFP-Atg8 (MMY120) cells were grown to log phase and transferred to SD-N medium for 20 min before being imaged as described in Materials and methods. Sequential images acquired with a time lapse of 5 s are shown. The arrow highlights the Atg9 reservoirs that ultimately colocalize with Atg8 in the process of becoming the PAS. The complete movie reconstruction is presented in [Video 1](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1). An identical result was obtained with cells expressing endogenous Atg9-GFP (FRY172) and carrying the pCumCheV5ATG8415 plasmid, which expresses mChe-Atg8 ([Video 2](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1)). DIC, differential interference contrast. Bar, 2 µm.](JCB_200912089_RGB_Fig9){#fig9}

Discussion
==========

To shed light on the long-standing issue in autophagy of how autophagosomes are generated, we investigated PAS biogenesis using Atg9 as a protein marker. We discovered that the Atg9 reservoirs are clusters of vesicles and tubules that are often adjacent to mitochondria but not continuous with them ([Fig. 2](#fig2){ref-type="fig"}, Fig. S1, and [Tables I](#tbl1){ref-type="table"} and [II](#tbl2){ref-type="table"}). The reason for the intimate connection between these two organelles remains unknown, and their proximity could be simply due to both organelles being associated with actin cables. Nevertheless, it is now clear that the Atg9 reservoirs are not directly generated from mitochondria. First, we never observed the membrane of the vesicles/tubules comprising this compartment in continuity with the mitochondrial outer membrane. Second, Atg9 was not detected on the surface of this organelle, and conversely, the mitochondrial protein markers Por1 and Idh1 were not found localizing to the Atg9 reservoirs ([Fig. 2, B--E](#fig2){ref-type="fig"}; [Fig. 3](#fig3){ref-type="fig"}; and Fig. S1). Finally, our studies about Atg9 biosynthesis show that this protein is translocated into the ER and reaches its final location via part of the secretory pathway ([Fig. 4](#fig4){ref-type="fig"}). Our results could appear to contradict published studies that suggested Atg9 localized at the mitochondria ([@bib40]; [@bib13]; [@bib36]; [@bib53]). In these studies, the mitochondrial localization of Atg9 was only hypothetical due to the resolution limits of fluorescence microscopy, and thus these previous analyses could not exclude the possibility that Atg9 is in a structure adjacent to mitochondria. Moreover, only a small fraction of Atg9-containing membranes ([Fig. 6 A](#fig6){ref-type="fig"}) are found associated with mitochondria in subcellular fractionation experiments ([@bib40]). Consequently, our data are not inconsistent with the literature, but rather explain previous observations and solve the discordance about Atg9 localization. It has been reported that the *sec12* mutation causes an Atg9 redistribution from preexisting Atg9 reservoirs to the mitochondria surface ([@bib36]). The Atg9 localization to mitochondria, however, was probably artifactual due to this organelle autofluorescence (unpublished data).

Based on our data, the Atg9 reservoirs emerge as a new organelle, and newly synthesized Atg9 is delivered to these sites through part of the secretory pathway ([Fig. 4](#fig4){ref-type="fig"}). Because of the only partial colocalization between newly synthesized Atg9 and the late Golgi protein marker Sec7 in *sec7* cells ([Fig. 4 B](#fig4){ref-type="fig"}), it remains unclear from which Golgi compartment Atg9 is exiting. In addition, it cannot be excluded that Atg9 passes through another organelle, and from there mediates the formation of the Atg9 reservoirs. These issues are currently being investigated in our laboratory. The Atg9 reservoirs are accessible to endocytic material, indicating that they are able to exchange materials with the endocytic system ([Fig. 5 A](#fig5){ref-type="fig"}). Atg9, however, shows minimal colocalization, and only modestly fractionates with protein markers of the EE, LE, and Golgi, which indicates that this protein concentrates in a unique organelle ([Fig. 5, B and C](#fig5){ref-type="fig"}; and [Fig. 7 C](#fig7){ref-type="fig"}; [@bib29]; [@bib39]; [@bib53]). In support of this, the disruption of the endocytic system with specific deletions such as that of *VPS4* leads to the concentration of endosomal proteins and several late Golgi factors into an abnormal, large LE adjacent to the vacuole ([@bib32], [@bib33]) without affecting Atg9 distribution or autophagy efficiency ([@bib5]; [@bib39]; [@bib36]).

It has been postulated that Atg9 is involved in supplying the nascent autophagosomes with lipid bilayers ([@bib38]). Here, we show that the PAS originates from at least one of the Atg9 reservoirs ([Figs. 8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"}). Thus, we argue that the initial membranes of the PAS and by extension of double-membrane vesicles are derived from the Atg9 reservoirs. We cannot exclude the possibility that during the expansion of the phagophore, additional lipid bilayers are obtained from a different source, e.g., from the ER, mitochondria, or Golgi ([@bib12]; [@bib9]; [@bib11]; [@bib49]).

In addition to the similar morphology between the Atg9 reservoirs and the PAS ([Figs. 1](#fig1){ref-type="fig"}, [6](#fig6){ref-type="fig"}, S1, and S4), one of our unpredicted discoveries has been the en bloc translocation of the reservoirs to form the PAS next to the vacuole. Our time-lapse fluorescence microscopy showed that the Atg machinery can be recruited to a single Atg9 reservoir ([Fig. 9](#fig9){ref-type="fig"} and Videos 1 and 2). When the Atg9 movement was triggered from the reservoirs to the PAS, we did not observe an increase in the number of isolated Atg9-containing vesicles and tubules in the cytoplasm ([Fig. 8](#fig8){ref-type="fig"}). These data support the notion that the Atg9 reservoirs move as clusters. This observation fits with our previous studies showing Atg9 present in cytoplasmic clusters ([@bib38], [@bib40]) and the demonstration that Atg9 self-interacts ([@bib40]; [@bib14]). An alternative model is that the PAS is generated by a small cluster of vesicles and/or tubules that results from the fragmentation of an Atg9 reservoir, but we do not consider this likely because we have never seen such a scission event during the live-cell imaging experiments, and small clusters comprising less than six vesicular and/or tubular profiles have only rarely been observed in our IEM preparations (see Materials and methods). All together, our data allow us to postulate a model where at least one Atg9 reservoir acts as a pre-PAS and where a change in localization of this compartment determines the biogenesis of the PAS ([Fig. 10](#fig10){ref-type="fig"}). The movement of an Atg9 reservoir in close proximity to the vacuole triggers the hierarchical recruitment of the remaining Atg proteins that mediate the rearrangement of these vesicles and tubules into what becomes the phagophore. It remains to be determined which factors on the vacuole limiting membrane or adjacent to it induce the Atg machinery assembly. Nonetheless, at this time we cannot conclusively rule out alternative models, and this hypothesis has to be experimentally demonstrated in future.

![**Model for the role of the Atg9 reservoirs in double-membrane vesicle formation.** The Atg9 reservoirs, which often are adjacent to mitochondria, act as a pre-PAS. Association with the prApe1 oligomer in nutrient-rich conditions (Cvt pathway) and probably cellular signals during starvation (autophagy) induces the translocation of one or more Atg9 reservoirs into close proximity with the vacuole. This relocalization event triggers the recruitment of the rest of the Atg proteins to a reservoir, leading to the formation of the PAS. Successive fusion of the tubulovesicular membranes composing the PAS and possibly acquisition of additional membrane from other Atg9 reservoirs and/or other sources creates a double-membrane vesicle.](JCB_200912089_GS_Fig10){#fig10}

The mammalian orthologue of Atg9 (mAtg9) cycles between the TGN and LE; and after autophagy stimulation, it relocalizes to autophagosomal membranes ([@bib54]). All the proteins encoded by the genes knocked out in our study possess orthologues, and some of them have also been implicated in mAtg9 trafficking ([@bib54]; [@bib17]; [@bib3]). Consequently, by extension, our results suggest that the origin of the initial autophagosomal membranes in higher eukaryotes could be the TGN and/or LE, and that the Atg9-positive membranes lead to the formation of the mammalian PAS after relocalization to the cell periphery, but this hypothesis remains to be experimentally tested.

The current hypothesis for double-membrane vesicle formation is that Atg proteins assemble at the PAS, and at this site, they mediate the formation of a phagophore that in turn expands into an autophagosome. Two main models have been proposed for the generation of phagophores: first, the generation by emergence from a defined organelle (which is supported by the recent observation according to which mammalian autophagosomes are generated in close proximity to the ER or mitochondria; [@bib12]; [@bib11]), and second, de novo formation by fusion of vesicles. Our results clearly support the model where the initial events of double-membrane vesicle biogenesis in yeast involve the de novo fusion of vesicles and tubules. One observation in support of de novo formation is that we have detected the Atg9-containing clusters of vesicles and tubules always positioned on one side of the Cvt complex, never completely surrounding this circular structure ([Fig. 2, D and E](#fig2){ref-type="fig"}; [Fig. 6, C--F](#fig6){ref-type="fig"}, cisternae circled with broken lines; Fig. S1, A--D and E; and Fig. S4, E--M). It is consequently tempting to imagine that the initial fusions generate a small cisterna, e.g., the phagophore. Our data do not exclude the possibility that after these early events, the completion of autophagosomes entails the acquisition of additional membranes through a different mechanism.

What would be the molecular basis for the fusion events? It has recently been shown that lipidated Atg8 mediates the tethering and hemifusion of membranes in vitro ([@bib28]). Our observations indicate that the early fusion events during double-membrane vesicle biogenesis probably do not require these Atg8 functions. In the *atg1Δ* and *atg13Δ* mutants, lipidated Atg8 is present at the PAS (Fig. S1, C--H; [@bib48]), but our micrographs clearly illustrate that the Atg9-containing vesicles and tubules are not hemifused ([Fig. 6, C--F](#fig6){ref-type="fig"}; and Fig. S4, E, F, and H--M). In *atg14Δ* cells, moreover, Atg8 is not associated with the PAS (Fig. S3, C--H; [@bib48]), but the Atg9-positive membranes appear to have undergone some fusion, and this is exemplified by the presence of larger tubular profiles ([Fig. 6, G and H](#fig6){ref-type="fig"}; and Fig. S4, N--Q). Our data are consistent with the observation that the tethering and hemifusion properties of lipidated Atg8 do not play a role before the expansion of the autophagosomal membranes ([@bib28]; [@bib46]). Because Sec18/NSF and SNARE proteins have so far not been implicated in double-membrane vesicle formation ([@bib16]; [@bib39]), future studies will have to address which factors carry out these initial fusion events. The Atg proteins are the most likely candidates because deletion of some of them leads to the formation of a PAS with different membrane rearrangement ([Fig. 6, C--H](#fig6){ref-type="fig"}; Fig. S2; and Fig. S4, D--Q). Our observations show that the protein composition of the PAS dictates the extent of fusion events ([Fig. 6, G and H](#fig6){ref-type="fig"}; and Fig. S4, N--Q) and possibly fission events ([Fig. 6, E and F](#fig6){ref-type="fig"}; and Fig. S4, C, D, and N--Q) occurring at this site. Atg14 is involved in the recruitment of the kinase complex that generates the PAS pool of phosphatidylinositol-3-phosphate ([@bib31]). Consequently, our results also indicate that the membrane rearrangements occurring at the PAS could be directly influenced by the lipid composition.

In conclusion, our work has revealed that the PAS is formed from a preexisting cluster of Atg9-containing vesicles and tubules whose composition is unique and from which atypical fusion events generate the double-membrane sequestering vesicles. This discovery provides the knowledge essential to perform further studies on the function of Atg proteins. Understanding the role of Atg proteins in rearranging and fusing membranes will be crucial to unveil the molecular mechanism of autophagy, which in turn will be essential to understand the contribution of this pathway in physiological and pathological situations.

Materials and methods
=====================

Plasmids
--------

To create the *ATG9-GFP* fusion under the control of a *TPI1* promoter (pATG9GFP416), *ATG9* was amplified by PCR and cloned as a HindIII--XmaI fragment into the pSNA3416 plasmid digested with HindIII--AgeI ([@bib37]). The 3′ primer used for this PCR reaction introduced a Gly-Ala-Gly-Ala-Gly-Ala-Gly protein linker between Atg9 and GFP. The integration vector pATG9GFP406 was generated by swapping *TPI1-ATG9-GFP* as a XhoI--SacI fragment into a pRS406 plasmid ([@bib44]). This construct leads to levels of Atg9-GFP eight times higher when compared with endogenous Atg9 as assessed by Western blotting. The plasmid expressing the Atg9-GFP chimera under the control of the *GAL1* promoter (pGalATG9416) was made by excising the *TPI1* promoter from the pATG9GFP416 vector with XhoI--HindIII and replacing it with that of *GAL1*, which was obtained by PCR from genomic DNA. The integration vector pATG9mCheV5403, which leads to the expression of Atg9-mChe-V5 under the control of a *TPI1* promoter, was created as follows: first, PCR-amplified *mCHE-V5* was cloned into the pSNA3416 plasmid as an AgeI--KpnI fragment, resulting in the pSNA3mCheV5416 plasmid. The *SNA3* gene was then excised from this plasmid with HindIII and AgeI, and replaced by PCR-amplified *ATG9* digested with HindIII and XmaI to produce the pATG9mCheV5416 plasmid. The integration vector pATG9mCheV5403 was finally made by swapping *TPI1-ATG9-mCHE-V5* as a XhoI--SacI fragment into a pRS403 plasmid ([@bib44]). As with the Atg9-GFP chimera ([Fig. 1](#fig1){ref-type="fig"}), the *TPI1* promoter-driven Atg9-mChe fusion protein is also functional.

The plasmids expressing monomeric RFP-Atg8 under the control of the authentic promoter (promRFPATG8415) were created in two steps. First, *GFP* was excised from the pRS316GFP--AUT7 plasmid (a gift of Y. Ohsumi, National Institute for Basic Biology, Okazaki, Japan; [@bib47]) with BamHI and replaced by the gene coding for RFP flanked by BamHI sites. The promoter and gene fusions were then shuttled into the pRS415 vector ([@bib44]). The plasmid expressing mChe-V5-Atg8 under the control of the *CUP1* promoter (pCumCheV5ATG8415) was created by excising and replacing *GFP* in the pCuGFPATG8415 vector ([@bib19]; [@bib47], [@bib48]), with PCR-generated *mCHE-V5* digested with SpeI--XmaI.

The plasmid pmitoDsRed415 was generated by digesting the pADHmitoDsRED ([@bib26]) vector with NotI--HindIII and cloning the resulting *ADH1* promoter-*mitoDsRED* fragment into the pRS415 vector using the same restriction enzymes.

Template plasmids for the PCR-based integration of the m*Cherry-V5* tag (pFA6a-mCherry-V5-TRP1, pFA6a-mCherry-V5-HIS3, and pFA6a-mCherry-V5-KanMX) at the 3′ end of genes were created as follows: the *GFP* gene was excised with PacI and AscI from the pFA6a-GFP-TRP1, pFA6a-GFP-HIS3, and pFA6a-GFP-KanMX vectors ([@bib24]), respectively, and replaced with the PCR-amplified *mCherry-V5*.

Plasmids pRS416, pJK1-2416, and those used for the genomic integration of Sec7-DsRED, GFP-Atg8, and RFP-Ape1 have been described previously ([@bib44]; [@bib29]; [@bib47]; [@bib38]; [@bib25]). The plasmid for the genomic integration of Sec7-DsRED was a gift of B. Glick (University of Chicago, Chicago, IL).

Strains
-------

The *S. cerevisiae* strains used in this study are listed in [Table III](#tbl3){ref-type="table"}. For gene disruptions, the *APE1*, *ATG1*, *ATG9*, *ATG11*, *ATG13*, and *ATG14* coding regions were replaced with the *Escherichia coli kan^r^*, the *S. cerevisiae TRP1*, or the *Saccharomyces pombe HIS5* genes using PCR primers containing ∼60 bases of identity to the regions flanking the open reading frame.

###### 

Strains used in this study

  Name       Genotype                                                                     Reference/origin
  ---------- ---------------------------------------------------------------------------- ------------------
  AFM69-1A   *MATa sec7-4 his3*,*11-15 leu2-3*,*112 ura3-1*                               [@bib39]
  BY4742     *MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0*                                           Euroscarf
  FBY217     *MATα sec12-4 his3 leu2 ura3 trp1 ade2*                                      [@bib39]
  FRY162     SEY6210 *ATG9-GFP*::*HIS5S.p.*                                               [@bib40]
  FRY172     SEY6210 *ATG9-PA*::*TRP1 pep4Δ::LEU2*                                        [@bib38]
  FRY196     SEY6210 *ATG9-PA*::*TRP1 atg1Δ::URA3 pep4Δ::LEU2*                            [@bib38]
  FRY250     SEY6210 *ATG9-PA*::*TRP1 atg11Δ::URA3 pep4Δ::LEU2*                           This study
  FRY300     *MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 pho13Δ::KAN pho8::PHO8Δ60 atg9Δ0*          This study
  FRY340     SEY6210 *ATG9-GFP*::*TRP1 VRG4-mCHE-V5*::*HIS5 S.p.*                         This study
  FRY341     SEY6210 *ATG9-GFP*::*TRP1 SEC7-dsRED*::*URA3*                                This study
  FRY342     SEY6210 *GFP-TLG1 ATG9-mCHE-V5*::*TRP1*                                      This study
  FRY344     SEY6210 *GFP-PEP12 ATG9-mCHE-V5*::*TRP1*                                     This study
  FRY360     SEY6210 *GFP-TLG1*                                                           This study
  JCK007     SEY6210 *atg9Δ::HIS3*                                                        [@bib29]
  MMY067     SEY6210 *atg9Δ::KAN TPI1-ATG9-GFP::URA3*                                     This study
  MMY068     SEY6210 *atg9Δ::KAN atg1Δ::HIS5 S.p. TPI1-ATG9-GFP::URA3*                    This study
  MMY069     SEY6210 *atg9Δ::KAN atg11Δ::HIS5 S.p. TPI1-ATG9-GFP::URA3*                   This study
  MMY070     SEY6210 *atg9Δ::KAN atg13Δ::HIS5 S.p. TPI1-ATG9-GFP::URA3*                   This study
  MMY071     SEY6210 *atg9Δ::KAN atg14Δ::HIS5 S.p. TPI1-ATG9-GFP::URA3*                   This study
  MMY072     SEY6210 *atg9Δ::KAN TPI1-ATG9-GFP::URA3 RFP-APE1::LEU2*                      This study
  MMY073     SEY6210 *atg9Δ::KAN atg1Δ::HIS5 S.p TPI1-ATG9-GFP::URA3 RFP-APE1::LEU2*      This study
  MMY074     SEY6210 *atg9Δ::KAN atg11Δ::HIS5 S.p TPI1-ATG9-GFP::URA3 RFP-APE1::LEU2*     This study
  MMY075     SEY6210 *atg9Δ::KAN atg13Δ::HIS5 S.p TPI1-ATG9-GFP::URA3 RFP-APE1::LEU2*     This study
  MMY076     SEY6210 *atg9Δ::KAN atg14Δ::HIS5 S.p TPI1-ATG9-GFP::URA3 RFP-APE1::LEU2*     This study
  MMY078     SEY6210 *atg9Δ::KAN atg1Δ::HIS5 S.p. ape1Δ::HIS5 S.p. TPI1-ATG9-GFP::URA3*   This study
  MMY120     SEY6210 *TPI1-ATG9-mCHE-V5::HIS3*                                            This study
  MMY125     BY4742 *SEC7-mCHE-V5::KAN*                                                   This study
  MMY126     BY4742 *SEC63-mCHE-V5::KAN*                                                  This study
  MMY127     *MAT*a *sec7-4-mCHE-V5::KAN his3*,*11-15 leu2-3*,*112 ura3-1*                This study
  MMY129     *MATα sec12-4 SEC63-mChe-V5::HIS3 leu2 ura3 trp1 ade2*                       This study
  MOY003     SEY6210 *atg9Δ::KAN TPI1-ATG9-GFP::URA3 IDH1-3xHA::HIS3*                     This study
  SEY6210    *MATα ura3-52 leu2-3*, *112 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 mel GAL*    [@bib41]

PCR-based integration of *GFP*, *mCHE-V5*, and a triple *HA* tag at the 3′ end of *ATG9*, *IDH1*, *SEC63*, *SEC7*, and *VRG4* was used to generate strains expressing C-terminal fusion proteins under the control of the native promoters. The template for integration was pFA6a-3xHA-HIS5, pFA6a-GFP-TRP1, pFA6a-mCherry-V5-TRP1, pFA6a-mCherry-V5-HIS3, and pFA6a-mCherry-V5-HIS3 ([@bib24]; and see Plasmids). PCR-based integration of *GFP* at the 5′ end of *TLG1* and *PEP12* followed by Cre recombinase-mediated excision of the auxotrophic marker was used to generate strains expressing N-terminal fusion proteins under the control of their native promoters ([@bib7]). The PCR template for integration was pOM43.

Western blotting using specific antibodies recognizing the proteins encoded by the deleted genes, analysis of the Ape1 processing, and PCR verification were used to confirm all deletions and integrations, and the functionality of all the genomic fusions.

Media
-----

Yeast cells were grown in rich (YPD; 1% yeast extract, 2% peptone, and 2% glucose) or synthetic minimal media (SMD; 0.67% yeast nitrogen base, 2% glucose, and amino acids and vitamins as needed). Starvation experiments were conducted by adding 200 ng/ml of rapamycin or by transferring cells into a nitrogen starvation medium (SD-N; 0.17% yeast nitrogen base without amino acids and ammonium sulfate, and 2% glucose).

Fluorescence microscopy
-----------------------

Yeast cells were grown in the appropriate medium before imaging. Endosomes were stained with FM 4-64 as described previously ([@bib45]). In brief, 1 ml of log phase cultures was centrifuged and resuspended in 100 µl of ice-cold medium containing 20 µM of FM 4-64 (Invitrogen). After 15 min on ice, cells were washed once with ice-cold medium without FM 4-64 and then resuspended in the same solution before being spotted on a cover slide. Preparations were successively imaged at RT over a 10-min period.

Fluorescence signals were captured with a fluorescence microscope system (DeltaVision RT; (Applied Precision) with a 100× objective lens, equipped with a CoolSNAP HQ camera (Photometrix). Images were generated by collecting a stack of 20 pictures with focal planes 0.20 µm apart to cover the entire volume of a yeast cell (4--5 µm) and by successively deconvolving and analyzing them with the softWoRx software (Applied Precision). A single focal plane is shown at each time point.

To perform statistical analyses of the colocalization degree between fluorescence signals, mild conditions were used to fix cells without destroying the fluorescent proteins ([@bib40]). The three-dimensional projection of the picture stacks allow for visualizing all the Atg9-positive puncta present in each cell. Subsequently, the number of these puncta colocalizing with the fluorescent organelle protein marker present in the same cells was determined. Percentages represent how many Atg9-positive puncta colocalize with a specific organelle protein marker. In total, ∼200--350 Atg9-positive puncta were analyzed for each time point, and this counting was repeated twice with samples from two independent experiments. Standard deviations between these two countings were calculated. To determine the number of Atg9-positive compartments per cell in strains expressing endogenous or overexpressed Atg9-GFP, the number of green puncta per cell was counted in 100 randomly chosen cells. Estimation of colocalization between endogenous or overexpressed Atg9-GFP puncta and mitochondria labeled with mitochondria-targeted DsRed was also performed in 100 randomly chosen cells. Three different categories of Atg9-GFP puncta were found. Those completely colocalizing with mitochondria were defined as overlapping and those adjacent or apposed to mitochondria were defined as adjacent, whereas those not in proximity to mitochondria were defined as free.

The time-lapse experiments were performed by imaging the same cells every 5 s for 4 min and 5 s (50 pictures). At each time point, images were generated by collecting a stack of three pictures with focal planes 0.20 µm apart and by successively deconvolving them.

IEM
---

Cells were fixed, embedded in gelatin, and cryo-sectioned as described previously ([@bib10]). Sections were then immuno-labeled using rabbit anti-GFP (Abcam) and anti-Ape1 antisera (a gift from I. Sandoval and M. Mazón, Universidad Autonoma de Madrid, Madrid, Spain), mouse anti-Por1 (Invitrogen), and anti-HA antibodies (a gift of G. Bu, Washington University in St. Louis, St. Louis, MO), and goat anti-GFP antibody (Rockland Immunochemicals, Inc.) follow by protein A (PA)-gold detection. The specificity of the antigenic reaction has been controlled for each single or double immunogold labeling that has been performed ([Fig. S5](http://www.jcb.org/cgi/content/full/jcb.200912089/DC1)). Sections were viewed in an electron microscope (1200 EX; JEOL).

Statistical analysis of IEM data
--------------------------------

The presence of gold particles associated with membranes comprising at least six vesicular and/or tubular profiles with a distance no greater than 10--15 nm defined an Atg9 cluster, whereas labeled single vesicles at a distance \>100 nm from a membranous structure, vesicle, or organelle, were defined as isolated vesicles. Membranes comprising 2--5 vesicular and/or tubular profiles have not been included in the statistical analyses because they were very rarely observed. A gold particle was assigned to a compartment when no further than 25 nm away from its limiting membrane. The number of Atg9 clusters and Cvt complexes per cell section were counted in wild-type, *atg11Δ*, and *atg1Δ* strains by randomly analyzing 250 cell profiles per strain over three independent experiments. This counting was also used to determine the number of cell sections positive for an Atg9 cluster or a Cvt complex.

The relative distribution of Atg9-GFP tubulovesicular clusters was assessed by randomly analyzing 150 sampled profiles from at least four distinct grids. These structures (adjacent or not to a Cvt complex) were designated as being associated with a well-defined organelle (nucleus, vacuole, or mitochondria) if within 50 nm from its limiting membrane. Structures further away were defined as cytoplasmic. Estimation of the average surface section of the Atg9 clusters was performed by analyzing 30 micrographs per condition using the point-hit method ([@bib34]).

Subcellular fractionation
-------------------------

Separation of membranes present in low-speed supernatant fractions on sucrose gradients were performed as described previously ([@bib39]). In brief, 500 OD~600~ equivalents of spheroplasts were lysed in 5 ml of ice-cold hypo-osmotic buffer (50 mM K~2~HPO~4~, pH 7.5, 200 mM sorbitol, and 1 mM EDTA) containing freshly added Complete protease inhibitors (Roche) and 2 mM PMSF by 20 aspirations through a syringe. Cell lysates were centrifuged twice at 500 *g* for 5 min, and 4 ml of the supernatant fractions (T) were subjected to centrifugation at 13,000 *g* for 15 min to be separated into supernatant (S13) and pellet (P13) fractions. The S13 fractions (2 ml) were subsequently loaded on a top of sucrose step gradients and centrifuged at 170,000 *g* for 16 h. All fractions were mixed with 4× Sample buffer, heated at 37°C for 5 min, and resolved by SDS-PAGE followed by Western blotting using antibodies or serum against GFP (Roche), V5 (Invitrogen), Tlg1 (a gift from H. Pelham, Medical Research Council Laboratory of Molecular Biology, Cambridge, England, UK), Por1, Pgk1, and Pep12 (all from Invitrogen).

Pho8 activity assay
-------------------

4 OD~600~ of cells in log phase or nitrogen-starved for 4 h were harvested by centrifugation, washed with 1 ml of ice-cold water, and resuspended in 400 µl of Lysis buffer (20 mM Pipes, pH 6.8, 0.5% Triton X-100, 50 mM KCl, 100 mM potassium acetate, 10 mM MgSO~4~, 10 µM ZnSO~4~, and 2 mM PMSF). The same volume of glass beads was added and cells were disrupted by agitation for 5 min. After pelleting of cell debris at 13,000 *g* for 5 min, 100 µl of lysate were mixed with 400 µl of reaction buffer (250 mM Tris-HCl, pH 8.5, 0.4% Triton TX-100, 10 mM MgSO~4~, 10 µM ZnSO~4~, and 1.25 mM p-nitrophenyl phosphate; Sigma-Aldrich) prewarmed at 37°C. Incubation was performed at 37°C for 20 min and stopped by adding 500 µl of 1 M glycine buffer, pH 11.0. Samples were then centrifuged at 13,000 *g* for 2 min, and 1 ml of supernatant was taken to measure the absorbance at OD~420~. Protein concentration in the lysate was determinate with a D~c~ Protein Assay kit (Bio-Rad Laboratories). Pho8 activity was calculated as (1,000 × OD~420~)/(min × \[prot\]), where min = 20 min and \[prot\] = protein concentration in the lysate expressed in mg/ml. Results were expressed in a plot as the percentage of the activity measured for the wild-type strain starved for nitrogen, with error bars representing the standard deviation from three experiments.

Ape1 analysis by Western blotting
---------------------------------

2.5 OD~600~ of cells grown in YPD to log phase were collected by centrifugation, and proteins were precipitated with 400 µl of ice-cold 10% trichloroacetic acid for 30 min. After spinning the samples for 5 min, pellets were washed with ice-cold acetone. Pellets were subsequently air dried, resuspended in 100 µl of sample buffer (80 mM Tris-HCl, pH 6.8, 2% SDS, 8.7% glycerol, 2.5% 2-mercaptoethanol, and 0.05% bromophenol blue), and boiled for 5 min. Aliquots of 20 µl were loaded on 8% SDS-PAGE gels, and after Western blotting, membranes were probed with the anti-Ape1 antibodies. The anti-Ape1 polyclonal antiserum was generated by injecting the synthetic peptide CKHWRSVYDEFGEL corresponding to amino acid residues 502--514 of Ape1 in New Zealand white rabbits (New England Peptide).

Online supplemental material
----------------------------

Fig. S1 shows [Fig. 2 (D and E)](#fig2){ref-type="fig"} without dashed lines as well as additional examples of Atg9 clusters in wild-type cells. Fig. S2 illustrates that Atg9 overexpression leads to an expansion of the membranes containing this protein without altering their biophysical properties. Fig. S3 shows the subcellular distribution of Atg9 in various mutant strains. Fig. S4 presents [Fig. 6 (C--F)](#fig6){ref-type="fig"} without dashed lines and ultrastructural views of Atg9 clusters in various mutant strains. Fig. S5 displays the immunogold labeling controls. Videos 1 and 2 show an Atg9 reservoir becoming the PAS. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200912089/DC1>.
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